Want to see TSE:CURA full AI Analyst Report?
Curaleaf Holdings (CURA) Ratios
Curaleaf Holdings Ratios
TSE:CURA's free cash flow for Q2 2026 was $13.10M. For the 2026 fiscal year, TSE:CURA's free cash flow was decreased by $-16.16M and operating cash flow was $29.26M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Mar 23 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.52 | 1.11 | 0.85 | 1.33 | 2.30 |
| Quick Ratio | 0.76 | 0.54 | 0.41 | 0.85 | 1.51 |
| Cash Ratio | 0.35 | 0.24 | 0.18 | 0.33 | 0.95 |
| Solvency Ratio | -0.01 | 0.02 | -0.04 | -0.11 | 0.02 |
| Operating Cash Flow Ratio | 0.48 | 0.42 | 0.15 | 0.09 | -0.11 |
| Short-Term Operating Cash Flow Coverage | 3.93 | 1.60 | 1.91 | 0.89 | -17.28 |
| Net Current Asset Value | $ -1.55B | $ -1.53B | $ -1.51B | $ -1.36B | $ -713.36M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.36 | 0.29 | 0.29 | 0.27 | 0.21 |
| Debt-to-Equity Ratio | 1.37 | 0.99 | 0.84 | 0.73 | 0.42 |
| Debt-to-Capital Ratio | 0.58 | 0.50 | 0.46 | 0.42 | 0.30 |
| Long-Term Debt-to-Capital Ratio | 0.40 | 0.35 | 0.34 | 0.31 | 0.23 |
| Financial Leverage Ratio | 3.76 | 3.42 | 2.95 | 2.67 | 2.01 |
| Debt Service Coverage Ratio | 0.84 | 0.66 | 0.89 | 0.50 | 1.31 |
| Interest Coverage Ratio | 0.25 | 0.20 | 0.43 | -0.12 | 2.24 |
| Debt to Market Cap | 0.29 | 0.49 | 0.20 | 0.20 | 0.07 |
| Interest Debt Per Share | 4.48 | 3.86 | 1.36 | 1.44 | 1.05 |
| Net Debt to EBITDA | 3.86 | 3.26 | 3.32 | 3.48 | 1.27 |
| Profitability Margins | |||||
| Gross Profit Margin | 38.61% | 47.61% | 45.63% | 43.33% | 56.84% |
| EBIT Margin | 2.01% | -1.27% | 3.18% | 4.86% | 4.84% |
| EBITDA Margin | 18.75% | 17.36% | 17.73% | 16.54% | 23.06% |
| Operating Profit Margin | 2.01% | 1.50% | 3.18% | -0.77% | 14.52% |
| Pretax Profit Margin | -6.17% | -8.76% | -9.24% | -16.94% | 5.36% |
| Net Profit Margin | -18.22% | -16.04% | -20.88% | -28.21% | -9.02% |
| Continuous Operations Profit Margin | -15.92% | -16.10% | -17.74% | -19.85% | -17.74% |
| Net Income Per EBT | 295.43% | 183.14% | 226.10% | 166.47% | -168.42% |
| EBT Per EBIT | -307.32% | -582.41% | -290.01% | 2209.49% | 36.89% |
| Return on Assets (ROA) | -8.28% | -7.30% | -9.08% | -11.04% | -3.51% |
| Return on Equity (ROE) | -31.14% | -25.01% | -26.76% | -29.45% | -7.06% |
| Return on Capital Employed (ROCE) | 1.02% | 0.79% | 1.65% | -0.35% | 6.30% |
| Return on Invested Capital (ROIC) | 0.99% | 0.75% | 1.61% | -0.34% | -10.53% |
| Return on Tangible Assets | -19.64% | -17.44% | -21.67% | -23.91% | -7.46% |
| Earnings Yield | -12.42% | -18.64% | -9.35% | -12.32% | -1.75% |
| Efficiency Ratios | |||||
| Receivables Turnover | 15.97 | 20.20 | 21.48 | 29.58 | 19.28 |
| Payables Turnover | 10.62 | 8.89 | 9.23 | 9.37 | 19.52 |
| Inventory Turnover | 3.52 | 3.19 | 3.39 | 3.23 | 2.10 |
| Fixed Asset Turnover | 1.77 | 1.75 | 1.62 | 1.53 | 1.72 |
| Asset Turnover | 0.45 | 0.46 | 0.43 | 0.39 | 0.39 |
| Working Capital Turnover Ratio | 13.18 | -79.75 | 31.35 | 4.67 | 3.98 |
| Cash Conversion Cycle | 92.18 | 91.49 | 85.08 | 86.56 | 173.72 |
| Days of Sales Outstanding | 22.86 | 18.07 | 16.99 | 12.34 | 18.93 |
| Days of Inventory Outstanding | 103.69 | 114.47 | 107.63 | 113.16 | 173.49 |
| Days of Payables Outstanding | 34.37 | 41.05 | 39.54 | 38.94 | 18.70 |
| Operating Cycle | 126.55 | 132.55 | 124.62 | 125.50 | 192.42 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 0.55 | 0.66 | 0.10 | 0.07 | -0.05 |
| Free Cash Flow Per Share | 0.30 | 0.26 | 0.01 | -0.13 | -0.29 |
| Dividend Paid and CapEx Coverage Ratio | 2.17 | 1.66 | 1.07 | 0.34 | -0.20 |
| Capital Expenditure Coverage Ratio | 2.17 | 1.66 | 1.07 | 0.34 | -0.20 |
| Operating Cash Flow Coverage Ratio | 0.14 | 0.19 | 0.09 | 0.05 | -0.05 |
| Operating Cash Flow to Sales Ratio | 0.11 | 0.12 | 0.06 | 0.03 | -0.03 |
| Free Cash Flow Yield | 4.01% | 5.57% | 0.17% | -3.01% | -3.30% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -8.01 | -5.37 | -10.70 | -8.11 | -57.20 |
| Price-to-Sales (P/S) Ratio | 1.47 | 0.86 | 2.23 | 2.29 | 5.16 |
| Price-to-Book (P/B) Ratio | 2.51 | 1.34 | 2.86 | 2.39 | 4.04 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 24.97 | 17.94 | 595.78 | -33.26 | -30.32 |
| Price-to-Operating Cash Flow Ratio | 13.48 | 7.11 | 39.97 | 65.92 | -183.80 |
| Price-to-Earnings Growth (PEG) Ratio | -1.16 | 0.57 | 0.27 | -0.04 | -1.26 |
| Enterprise Value Multiple | 11.68 | 8.22 | 15.92 | 17.32 | 23.64 |
| Enterprise Value | 2.83B | 1.92B | 3.80B | 3.83B | 6.60B |
| EV to EBITDA | 11.68 | 8.22 | 15.92 | 17.32 | 23.64 |
| EV to Sales | 2.19 | 1.43 | 2.82 | 2.86 | 5.45 |
| EV to Free Cash Flow | 37.29 | 29.75 | 752.68 | -41.62 | -32.03 |
| EV to Operating Cash Flow | 20.14 | 11.79 | 50.49 | 82.48 | -194.19 |
| Tangible Book Value Per Share | -3.17 | -2.91 | -0.87 | -0.62 | 0.07 |
| Shareholders’ Equity Per Share | 2.97 | 3.48 | 1.45 | 1.80 | 2.21 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | -1.58 | -0.84 | -0.92 | -0.66 | 2.68 |
| Revenue Per Share | 5.08 | 5.43 | 1.86 | 1.88 | 1.73 |
| Net Income Per Share | -0.93 | -0.87 | -0.39 | -0.53 | -0.16 |
| Tax Burden | 2.95 | 1.83 | 2.26 | 1.66 | -1.68 |
| Interest Burden | -3.07 | 6.91 | -2.90 | -3.48 | 1.11 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.36 | 0.33 | 0.31 | 0.32 | 0.31 |
| Stock-Based Compensation to Revenue | 0.03 | 0.02 | 0.01 | 0.02 | 0.03 |
| Income Quality | -0.70 | -0.75 | -0.31 | -0.12 | 0.31 |
Currency in USD